Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stadler

Showing results (461-470 of 724) with videos related to

Pageof 73
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2012
Resampling phase III data to assess phase II trial designs and endpointsManish R Sharma, Theodore G Karrison, Yuyan Jin, et al.
European Journal of Immunology|June 1, 1984
Interleukin 2-independent stimulation of rabbit chondrocyte collagenase and prostaglandin E2 production by an interleukin 1-like factorV Evêquoz, F Bettens, F Kristensen, et al.
The Lancet. Global Health|September 24, 2020
Early-life respiratory syncytial virus lower respiratory tract infection in a South African birth cohort: epidemiology and effect on lung healthHeather J Zar, Polite Nduru, Jacob A M Stadler, et al.
Journal of Medical Case Reports|March 19, 2021
Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case reportJacobi Hines, Ellen Daily, Anh Khoa Pham, et al.
Cancer Medicine|October 25, 2013
FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancerJames L Chen, Daniel E Appelbaum, Masha Kocherginsky, et al.
Cancer|May 20, 2008
Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinomaEric Jonasch, Walter M Stadler, Ronald M Bukowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2000
Molecular basis for nonanaphylactogenicity of a monoclonal anti-IgE antibodyM P Rudolf, A W Zuercher, A Nechansky, et al.
Urologic Oncology|September 26, 2025
The comeback of orchiectomy in advanced prostate cancer- is that feasible?Alon Lazarovich, Walter M Stadler, Scott Eggener, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4B R Konety, T S Nguyen, R Dhir, et al.
Agents and Actions. Supplements|January 1, 1993
A specific feedback by anti-IgE autoantibodies on the cytokine network in allergyB M Stadler, M R Stämpfli, M Vogel, et al.
Pageof 73

Showing results (461-470 of 724) with videos related to

Sort By:
Pageof 73
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2012
Resampling phase III data to assess phase II trial designs and endpointsManish R Sharma, Theodore G Karrison, Yuyan Jin, et al.
European Journal of Immunology|June 1, 1984
Interleukin 2-independent stimulation of rabbit chondrocyte collagenase and prostaglandin E2 production by an interleukin 1-like factorV Evêquoz, F Bettens, F Kristensen, et al.
The Lancet. Global Health|September 24, 2020
Early-life respiratory syncytial virus lower respiratory tract infection in a South African birth cohort: epidemiology and effect on lung healthHeather J Zar, Polite Nduru, Jacob A M Stadler, et al.
Journal of Medical Case Reports|March 19, 2021
Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case reportJacobi Hines, Ellen Daily, Anh Khoa Pham, et al.
Cancer Medicine|October 25, 2013
FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancerJames L Chen, Daniel E Appelbaum, Masha Kocherginsky, et al.
Cancer|May 20, 2008
Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinomaEric Jonasch, Walter M Stadler, Ronald M Bukowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2000
Molecular basis for nonanaphylactogenicity of a monoclonal anti-IgE antibodyM P Rudolf, A W Zuercher, A Nechansky, et al.
Urologic Oncology|September 26, 2025
The comeback of orchiectomy in advanced prostate cancer- is that feasible?Alon Lazarovich, Walter M Stadler, Scott Eggener, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4B R Konety, T S Nguyen, R Dhir, et al.
Agents and Actions. Supplements|January 1, 1993
A specific feedback by anti-IgE autoantibodies on the cytokine network in allergyB M Stadler, M R Stämpfli, M Vogel, et al.
Pageof 73